Literature DB >> 2026197

Central beta-endorphin system involvement in the reaction to acute tonic pain.

C A Porro1, G Tassinari, F Facchinetti, A E Panerai, G Carli.   

Abstract

The involvement of the beta-endorphin (B-EP) system during acute prolonged (tonic) pain was investigated by biochemical and behavioral approaches in freely-moving rats after subcutaneous injection of a small amount of a dilute formaldehyde solution (0.08 ml, 5%) in a forepaw. Beta-endorphin-like immunoreactivity levels were increased over the respective control groups in rats killed 30, 60 and 120 min after injection in discrete regions of the rat brain, namely ventro-medial hypothalamus, ventro-basal thalamus and periaqueductal gray matter, and at 30 and 60 min in postero-medial thalamus. In a separate group of experiments a small amount of anti-B-EP or normal rabbit serum was injected in the lateral ventricle; 6 h later rats received formalin injection as in previous groups and their behavior was scored over the following 2 h. A significant hyperalgesia (as expressed by an increase in the amount of time rats spent licking or chewing the injected paw) was observed 10-50 min and 70-80 min after formalin in the anti-B-EP icv-injected group. Other behavioral parameters such as general motor activity, grooming and limb flexion were not different in the two groups, nor was animal behavior prior to formalin injection. Altogether these data suggest that the central beta-endorphin system is triggered by prolonged noxious stimulation in freely-moving animals, and in turn plays a physiological role in the modulation of the reaction to, or perception of, tonic pain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026197     DOI: 10.1007/bf00229833

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  33 in total

Review 1.  Multiple opioid systems and pain.

Authors:  M J Millan
Journal:  Pain       Date:  1986-12       Impact factor: 6.961

2.  Habenular stimulation produces analgesia in the formalin test.

Authors:  S R Cohen; R Melzack
Journal:  Neurosci Lett       Date:  1986-09-25       Impact factor: 3.046

3.  Paradoxical effects of low doses of naloxone in experimental models of inflammatory pain.

Authors:  V Kayser; J M Besson; G Guilbaud
Journal:  Prog Brain Res       Date:  1988       Impact factor: 2.453

4.  Isolated removal of hypothalamic or other brain nuclei of the rat.

Authors:  M Palkovits
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

5.  Medial thalamic injection of opioid agonists: mu-agonist increases while kappa-agonist decreases stimulus thresholds for pain and reward.

Authors:  K D Carr; T H Bak
Journal:  Brain Res       Date:  1988-02-16       Impact factor: 3.252

6.  Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.

Authors:  A E Panerai; A Martini; P Sacerdote; P Mantegazza
Journal:  Brain Res       Date:  1984-06-18       Impact factor: 3.252

7.  Analgesia produced by normal doses of opioid antagonists alone and in combination with morphine.

Authors:  Anthony L Vaccarino; R A R Tasker; Ronald Melzack
Journal:  Pain       Date:  1989-01       Impact factor: 6.961

8.  Shock-induced analgesia on the formalin test: effects of shock severity, naloxone, hypophysectomy, and associative variables.

Authors:  M S Fanselow
Journal:  Behav Neurosci       Date:  1984-02       Impact factor: 1.912

9.  Noxious stimuli and Met-enkephalin release from nucleus reticularis gigantocellularis.

Authors:  Y Kuraishi; M Sugimoto; T Hamada; Y Kayanoki; H Takagi
Journal:  Brain Res Bull       Date:  1984-01       Impact factor: 4.077

10.  Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain.

Authors:  J C Finley; P Lindström; P Petrusz
Journal:  Neuroendocrinology       Date:  1981-07       Impact factor: 4.914

View more
  4 in total

1.  Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.

Authors:  Michelle R Hoot; Laura J Sim-Selley; Dana E Selley; Krista L Scoggins; William L Dewey
Journal:  Brain Res       Date:  2011-06-16       Impact factor: 3.252

2.  Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.

Authors:  Amy C Jongeling; Malcolm E Johns; Anne Z Murphy; Donna L Hammond
Journal:  Neuropharmacology       Date:  2009-03-03       Impact factor: 5.250

Review 3.  Research Tools for the Measurement of Pain and Nociception.

Authors:  Craig Johnson
Journal:  Animals (Basel)       Date:  2016-11-11       Impact factor: 2.752

Review 4.  Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.

Authors:  Nicolas B Senese; Ram Kandasamy; Kelsey E Kochan; John R Traynor
Journal:  Front Mol Neurosci       Date:  2020-01-24       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.